Skip to search.
 FTSE 100 Down 0.86%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
6.14 Down 0.36(5.54%) 5 Feb 21:00
|After Hours: : 6.14 0.00 (0.00%) 21:57
Prev Close:6.50
Open:6.62
Bid:N/A
Ask:6.66 x 200
1y Target Est:16.33
Beta:2.68404
Next Earnings Date:23-Feb-16BCRX Earnings announcement
Day's Range:6.09 - 6.75
52wk Range:6.09 - 16.83
Volume:1,352,548
Avg Vol (3m):731,648
Market Cap:450.29m
P/E (ttm):N/A
EPS (ttm):-0.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BCRX at this time.

Comparison

Symbol% ChgMkt Cap
BCRXDown 5.54%450.29m
GSKDown 0.54%98.64b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.61
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-0.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback